Sinovac High-dosage PCV24: Clinical Trials

1 trial of Sinovac High-dosage PCV24, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Sinovac High-dosage PCV24: new trials by email Literature Review of Sinovac High-dosage PCV24 trials Research Report on Sinovac High-dosage PCV24

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of PCV24 in Adults Aged ≥18 Years
Sinovac Low-dosage PCV24, Sinovac Middle-dosage PCV24, Sinovac High-dosage PCV24 - Pneumococcal Infectious Disease
Phase 1 / Phase 2CompletedSinovac Life Sciences Co., Ltd.3852025-06-182026-04-21

Conditions studied

Pneumococcal Infections (1)

Sponsors

Sinovac Life Sciences Co., Ltd. (1)

Countries

China (1)

Top investigators

Weijun Hu (1)